Skin metastases of malignant melanoma: A clinical and prognostic survey

Melanoma Research

Volumn 19, Issue 5, 2009, Pages 321-326

  Savoia, Paola ^a   Fava, Paolo ^a   Nardò, Tiziana ^a   Osella Abate, Simona ^a   Quaglino, Pietro ^a   Bernengo, Maria Grazia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cutaneous metastases; Melanoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SKIN METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 73349123456     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32832ac775     Document Type: Article

References (36)

1. Spencer PS, Helm TN. Skin metastases in cancer patients. Cutis 1987; 39:119-121.
2. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29:228-236.
3. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33:161-182.
4. Hu SC, Chen GS, Lu YW, Wu CS, Lan CC. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal. J Eur Acad Dermatol Venereol 2008; 22:735-740.
5. Sariya D, Ruth K, Adams-McDonnell R, Cusack C, Xu X, Elenitsas R, et al.Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol 2007; 143:613-620.
6. Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS. The frequency of local recurrence and microsatellites as a guide to reexcision of margins for cutaneous malignant melanoma. Ann Surg 1984; 200:759-763.
7. Buzaid AC, Ross MI, Balch CM, Soong S, McCarthy WH, Tinoco L. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15:1039-1051.
8. Borgstein PJ, Meijer S, van Diest PJ. Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 1999; 6:315-321.
9. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol 2004; 31:419-430.
10. Schwartz RA. Histopathologic aspect of cutaneous metastatic disease. J Am Acad Dermatol 1995; 33:649-657.
11. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-3634.
12. Bernengo MG, Doveil GC, Lisa F, Pippione M, Aloi FG, Stuardi C, et al. Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985). Giorn Ital Dermatol Venerol 1986; 121:311-326.
13. Cook J. Surgical margins for resection of primary cutaneous melanoma. Clin Dermatol 2004; 22:228-233.
14. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, et al. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res 2008; 18:61-67.
15. Bernengo MG, Quaglino P, Cappello N, Fierro MT, Doveil GC, MacripòG, et al. Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004. Giorn Ital Dermatol Venereol 2005; 140:191-200.
16. Quaglino P, Borgognoni L, Bottoni U, Calvieri S, Carli P, Catricalà C, et al. Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients. Giorn Ital Dermatol Venereol 2007; 142:41-47.
17. Francken AB, Accort NA, Shaw HM,Wiener M, Soong S, Hoekstra HJ, et al. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol 2008; 15:1476-1484.
18. Wolf IH, Richtig E, Kopera D, Kerl H. Locoregional cutaneous metastases of malignant melanoma and their management. Dermatol Surg 2004; 30:244-247.
19. Hayes AJ, Clark MA, Harries M, Thomas JM. Management of in-transit metastases from cutaneous malignant melanoma. Br J Surg 2004; 91:673-682.
20. Aitken DR, James AG, Carey LC. Local cutaneous recurrence after conservative excision of malignant melanoma. Arch Surg 1983; 198:65-69.
21. Cascinelli N, Bufalino R, Marolda R, Belli F, Nava M, Galluzzo D. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 1986; 12:175-180.
22. Heenan PJ, Ghaznawie M. The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg 1999; 52:209-213.
23. Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R, Kopf AW. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983; 198:65-69.
24. Reintgen DS, Cox C, Slingluff CL, Seigler HF. Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg 1992; 28:45-49.
25. Fusi S, Ariyan S, Sternlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population. Plast Reconstr Surg 1993; 91:94-98.
26. Cohn-Cedermark G, Månsson-Brahme E, Rutqvist LE, Larsson O, Singnomklao T, Ringborg U. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study. Cancer 1997; 80:1418-1425.
27. Kretschmer L, Preusser K-P, Neumann C. Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: risk factors and prognostic impact. Melanoma Res 2002; 12:499-504. (Pubitemid 35264727)
28. Karakousis CP, Choe KJ, Holyoke ED. Biologic behavior and treatment of intransit metastases of melanoma. Surg Gynecol Obstet 1980; 150:29-32.
29. McHugh JB, Su L, Griffith KA, Schwartz JL, Wong SL, Cimmino V, et al. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 2006; 13:1216-1223.
30. Osella-Abate S, Savoia P, Cambieri I, Salomone B, Quaglino P, Bernengo MG. Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma. Melanoma Res 2000; 10:545-555.
31. Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995; 75:2492-2498.
32. Dong XD, Tyler D, Johnson JL, DeMatos P, Seigler HF. Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer 2000; 88:1063-1071.
33. Rols MP, Bachaud JM, Giraud P, Chevreau C, RocháH, TeissiáJ. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res 2000; 10:468-474.
34. Gothelf A, Mir M, Gelh J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29:371-387.
35. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15:2215-2222.
36. Zrada S, Laucius JF, Nathan F, Sato T, Mastrangelo MJ, Berd D. Complete remission of metastatic melanoma after treatment with the Darmouth regimen. Proc Am Soc Clin Oncol 2001; 20:361a.